Ventricular-vascular coupling is predictive of adverse clinical outcome in paediatric pulmonary arterial hypertension
Related Experiment Video
Updated: Oct 18, 2025

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
Melanie J Dufva1,2,3, Dunbar Ivy2,3, Kristen Campbell2,3
1Bioengineering, University of Colorado Denver - Anschutz Medical Campus, Aurora, Colorado, USA melanie.dufva@cuanschutz.edu.
Insights
Ventricular-vascular coupling (Ees/Ea) derived from right ventricular pressure alone predicts adverse outcomes in pediatric pulmonary arterial hypertension (PAH). This metric shows prognostic capacity, especially in idiopathic/hereditary PAH, aiding clinical management.
Area of Science:
- Cardiology
- Pediatric Pulmonology
- Hemodynamics
Background:
- Ventricular-vascular coupling (Ees/Ea) is a key hemodynamic metric.
- Pulmonary arterial hypertension (PAH) in children requires effective prognostic tools.
- Assessing Ees/Ea using only right ventricular pressure could simplify prognostic evaluation in pediatric PAH.
Purpose of the Study:
- To evaluate the prognostic capability of the ventricular-vascular coupling ratio (Ees/Ea) in pediatric patients with PAH.
- To determine if Ees/Ea, calculated solely from right ventricular pressure, can predict clinical outcomes.
- To compare the prognostic value of Ees/Ea in different subtypes of pediatric PAH (IPAH/HPAH vs. APAH).
Main Methods:
- Retrospective review of 130 pediatric PAH patients diagnosed via right heart catheterization.
- Calculation of Ees/Ea using two single-beat methods (Takeuchi and Kind) based on right ventricular pressure.
- Cox proportional hazard modeling to assess the association between Ees/Ea and time to clinical events (soft and hard).
Main Results:
- In idiopathic/hereditary PAH (IPAH/HPAH), both Ees/Ea_Kind and Ees/Ea_Takeuchi were independently associated with time to hard adverse events, even after adjusting for indexed pulmonary vascular resistance.
- Neither Ees/Ea method was associated with time to soft adverse events in IPAH/HPAH patients.
- In associated PAH (APAH) patients, Ees/Ea did not show a significant association with either hard or soft adverse events.
Conclusions:
- Ventricular-vascular coupling (Ees/Ea) derived from pressure alone is a potent independent predictor of adverse outcomes in pediatric PAH.
- This pressure-derived Ees/Ea ratio holds potential as a valuable prognostic tool for managing children with PAH.
- The prognostic utility of Ees/Ea appears more pronounced in IPAH/HPAH compared to APAH.
Aims:
Ventricular-vascular coupling, the ratio between the right ventricle's contractile state (Ees) and its afterload (Ea), may be a useful metric in the management of paediatric pulmonary arterial hypertension (PAH). In this study we assess the prognostic capacity of the ventricular-vascular coupling ratio (Ees/Ea) derived using right ventricular (RV) pressure alone in children with PAH.
Methods:
One hundred and thirty paediatric patients who were diagnosed with PAH via right heart catheterisation were retrospectively reviewed over a 10-year period. Maximum RV isovolumic pressure and end-systolic pressure were estimated using two single-beat methods from Takeuchi et al (Ees/Ea_(Takeuchi)) and from Kind et al (Ees/Ea_(Kind)) and used with an estimate of end-systolic pressure to compute ventricular-vascular coupling from pressure alone. Patients were identified as either idiopathic/hereditary PAH or associated PAH (IPAH/HPAH and APAH, respectively). Haemodynamic data, clinical functional class and clinical worsening outcomes-separated into soft (mild) and hard (severe) event categories-were assessed. Adverse soft events included functional class worsening, syncopal event, hospitalisation due to a proportional hazard-related event and haemoptysis. Hard events included death, transplantation, initiation of prostanoid therapy and hospitalisation for atrial septostomy and Pott's shunt. Cox proportional hazard modelling was used to assess whether Ees/Ea was predictive of time-to-event.
Results:
In patients with IPAH/HPAH, Ees/Ea_(Kind) and Ees/Ea_(Takeuchi) were both independently associated with time to hard event (p=0.003 and p=0.001, respectively) and when adjusted for indexed pulmonary vascular resistance (p=0.032 and p=0.013, respectively). Neither Ees/Ea_(Kind) nor Ees/Ea_(Takeuchi) were associated with time to soft event. In patients with APAH, neither Ees/Ea_(Kind) nor Ees/Ea_(Takeuchi) were associated with time to hard event or soft event.
Conclusions:
Ees/Ea derived from pressure alone is a strong independent predictor of adverse outcome and could be a potential powerful prognostic tool for paediatric PAH.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure II: Pathophysiology
Mitral Stenosis I: Introduction

